Published in Cancer Weekly, October 4th, 2005
Study 1: Transposon-based systems seek insertion sites to improve viral gene delivery.
According to a study from the United States, "therapeutic gene delivery from an oncolytic adenovirus (Ad) is one approach to enhancing the potency of Ad-based virotherapies for cancer. To identify therapeutic transgene insertion sites compatible with the replicating virus, a methodology that broadly scans the viral genome is needed."
"To address this we modified a transposon (Tn7)-based in vitro transposition system to take advantage of its nonprejudiced scanning...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2005-10-04)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.